Filtered By:
Vaccination: AIDS Vaccine
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 1157 results found since Jan 2013.
COVID-19 and autoimmune diseases of the nervous system - an update
Neurol Neurochir Pol. 2023 Feb 17. doi: 10.5603/PJNNS.a2023.0008. Online ahead of print.ABSTRACTINTRODUCTION: Due to a similar pathomechanism, COVID-19 infection may significantly affect the course of autoimmune diseases (AIDs). In our review, we aimed to assess the severity of SARS-CoV-2 infection, response to treatment, and the impact of COVID-19 infection on the course of the underlying disease in patients with neuroimmune diseases.STATE OF THE ART: In the time of the COVID-19 pandemic, it was important to determine the influence of COVID-19 infection on the course of autoimmune diseases due to the weakened immune syste...
Source: Neurologia i Neurochirurgia Polska - February 17, 2023 Category: Neurology Authors: Natalia Morawiec Bo żena Adamczyk Monika Adamczyk-Sowa Source Type: research
Mixed Origins: HIV gp120-specific memory develops from pre-existing memory and na ïve B cells following vaccination in humans
AIDS Res Hum Retroviruses. 2023 Feb 10. doi: 10.1089/AID.2022.0104. Online ahead of print.ABSTRACTThe most potent and broad HIV envelope (Env)-specific antibodies often when reverted to their inferred germline versions representing the naïve B cell receptor, fail to bind Env suggesting that the initial responding B cell population is not exclusively comprised of a naïve population, but also a pre-existing cross-reactive antigen-experienced B cell pool that expands following Env exposure. Previously we isolated gp120-reactive monoclonal antibodies (mAbs) from participants in HVTN 105, an HIV vaccine trial. Using deep sequ...
Source: Cell Research - February 10, 2023 Category: Cytology Authors: Madhubanti Basu Christopher Fucile Michael Piepenbrink Catherine Bunce Li-Xing Man Jane Liesveld Alexander Rosenberg Michael Keefer James J Kobie Source Type: research
Chronic medical conditions associated with invasive pneumococcal diseases in inpatients in teaching hospitals in S ão Paulo city: Estimating antimicrobial susceptibility and serotype-coverage of pneumococcal vaccines
CONCLUSION: Vaccine with expanded valence of serotypes is necessary to offer broad prevention to IPD. The present data contribute to pneumococcal vaccination public health policies for vulnerable patients, mainly those with comorbidity and the elderly.PMID:36758625 | DOI:10.1016/j.bjid.2023.102746
Source: Braz J Infect Dis - February 9, 2023 Category: Infectious Diseases Authors: Renato A Kfouri Maria-Cristina C Brandileone Marco Aur élio P Sáfadi Rosana Richtmann Alfredo E Gilio Flavia Rossi Thais Guimar ães Ana Luiza Bierrenbach Jos é C Moraes S ão Paulo Study Group for IPD Source Type: research
